Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 9, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 28
- 0 vs. Q1 2024
- Portfolio value
- $267.7M
- −$87.1M (−24.6%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Stock | 420,163 | $28.8M | 10.8% | +154,544+58.2% | Added | History |
| PFEPfizer Inc | Stock | 895,000 | $25.0M | 9.4% | −344,165−27.8% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 535,000 | $22.2M | 8.3% | +36,464+7.3% | Added | History |
| MDTMedtronic plc | Stock | 264,890 | $20.8M | 7.8% | −147,003−35.7% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 24,279 | $13.2M | 4.9% | −10,018−29.2% | Reduced | History |
| CVSCVS Health Corp | Stock | 220,000 | $13.0M | 4.9% | −88,004−28.6% | Reduced | History |
| INCYIncyte Corp | COM | 203,376 | $12.3M | 4.6% | −61,519−23.2% | Reduced | History |
| CAHCardinal Health Inc | Stock | 107,098 | $10.5M | 3.9% | −75,489−41.3% | Reduced | History |
| BIIBBiogen Inc. | COM | 43,985 | $10.2M | 3.8% | −15,713−26.3% | Reduced | History |
| AMGNAmgen Inc | Stock | 30,000 | $9.37M | 3.5% | +30,000 | New | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 85,000 | $9.23M | 3.4% | −36,033−29.8% | Reduced | History |
| BAXBaxter International Inc | Stock | 260,000 | $8.70M | 3.2% | −63,120−19.5% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 104,000 | $8.10M | 3.0% | −19,133−15.5% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 170,000 | $8.10M | 3.0% | −5,507−3.1% | Reduced | History |
| BRKRBruker Corp | COM | 115,472 | $7.37M | 2.8% | +2,697+2.4% | Added | History |
| ABTAbbott Laboratories | Stock | 70,000 | $7.27M | 2.7% | +70,000 | New | History |
| THCTenet Healthcare Corp | COM NEW | 52,861 | $7.03M | 2.6% | −24,674−31.8% | Reduced | History |
| UHSUniversal Health Services Inc | CL B | 35,000 | $6.47M | 2.4% | −34,881−49.9% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 69,153 | $6.39M | 2.4% | −37,713−35.3% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 121,844 | $5.25M | 2.0% | −42,534−25.9% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 63,348 | $5.22M | 1.9% | −18,068−22.2% | Reduced | History |
| ALKSAlkermes plc. | SHS | 194,000 | $4.68M | 1.7% | −58,319−23.1% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 16,829 | $4.60M | 1.7% | −16,833−50.0% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 15,240 | $3.70M | 1.4% | −12,343−44.7% | Reduced | History |
| QGENQiagen N.V. | Stock | 83,484 | $3.43M | 1.3% | −19,885−19.2% | Reduced | History |
| CNCCentene Corp | Stock | 45,000 | $2.98M | 1.1% | +22,784+102.6% | Added | History |
| LNTHLantheus Holdings, Inc. | Stock | 31,712 | $2.55M | 1.0% | −21,348−40.2% | Reduced | History |
| VTRSViatris Inc | Stock | 103,106 | $1.10M | 0.4% | −314,551−75.3% | Reduced | History |
Sold out since Q1 2024 (2)
Positions held at the end of Q1 2024 that are gone from this filing.